Table 2 Measures
Measures | Time point |
|---|---|
Screening | |
 PTSD symptoms (PCL-5) | Screening |
 Trauma history (THS) | Screening |
 Psychiatric comorbidities (DIAMOND) | Screening |
 PTSD symptoms (CAPS-5) | Screening |
 Suicide risk (C-SSRS) | Screening |
Primary outcome | |
 PTSD symptoms (CAPS-5) | Baseline, post-tx, 3-month, 6-month |
Secondary outcomes | |
 PTSD symptoms (PCL-5) | Baseline, post-tx, 3-month, 6-month |
 Functioning (B-IPF) | Baseline, post-tx, 3-month, 6-month |
 Depression (PHQ-9) | Baseline, post-tx, 3-month, 6-month |
 Suicide risk (C-SSRS) | Baseline, post-tx, 3-month, 6-month |
 Pain Catastrophizing Scale | Baseline, post-tx, 3-month, 6-month |
 WHO Disability Assessment Schedule (WHODAS 2.0) | Baseline, post-tx, 3-month, 6-month |
 Patient satisfaction (CSQ-8) | Baseline, post-tx |
 Service utilization | Baseline, post-tx, 3-month, 6-month |
Mechanisms and/or mediators | |
 Posttraumatic cognitions (PTCI-9) | Baseline, post-tx, 3-month, 6-month |
 Treatment engagement | Weekly during treatment |
Moderators | |
 Demographics | Baseline |
 Psychiatric comorbidities (DIAMOND) | Baseline |
 Trauma type (THS) | Screening |
Fidelity measures | |
 Content checklists | Weekly |
 Review session audio | Weekly |
 CPT fidelity measure | Weekly |